1. Singapore Ocular Tuberculosis Immunity Study (SPOTIS): Role of T-lymphocyte Profiling in Patients with Presumed Ocular Tuberculosis.
- Author
-
Hutchinson, Paul E., Kee, Ae Ra, Agrawal, Rupesh, Yawata, Nobuyo, Tumulak, Mayjane Jg, Connolly, John E., Chee, Soon-Phaik, and Siak, Jay
- Subjects
CD4 antigen ,TUBERCULOSIS ,CD38 antigen ,T cells ,IMMUNITY ,TUBERCULOSIS diagnosis ,DRUG therapy for tuberculosis ,BACTERIAL proteins ,FLOW cytometry ,RESEARCH ,CASE-control method ,BACTERIAL antigens ,EVALUATION research ,COMPARATIVE studies ,ANTITUBERCULAR agents ,IMMUNOPHENOTYPING ,MYCOBACTERIUM tuberculosis ,RESEARCH funding ,CELLULAR immunity ,LONGITUDINAL method - Abstract
Objective: A prospective clinical study to assess the utility of CD4 + T cell lymphocyte profiling from peripheral blood in patients with ocular tuberculosis (TB).Methods: Thirty-six Asian patients with presumed diagnosis of ocular TB were recruited for T-lymphocyte profiling. MTB antigen specific CD4 assay was set up, and flow cytometric data were analyzed using FlowJo software.Results: There was no significant difference between treatment responders and non-responders for the proportion of CD4 + T cells specific for PPD or ESAT-6+ CFP-10, but treatment responders did have significantly higher frequency of CD38+ (p = .0357) and CD38+ HLA-DR+ (p = .0357) on the PPD-specific CD4 + T cells.Conclusion: This study is one of the first of its kind to look into MTB specific T cell activation marker profiling of peripheral blood in patients with ocular TB. Further studies need to be undertaken to assess the utility of CD4 + T cell phenotypes as a biomarker for ocular TB. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF